Skip to main content

Investors
News
Documents
Jobs
Contact

Enter your keywords

VIP Club

A revolutionary biocide
Industry oriented service
Strong R&D arguments
Impact on society
About Amoéba

Media contact

You are here

Home / News / Media contact

News

Press releases
Media clipping
Media contact

Contact

Valérie FILIATRE
Directrice Administrative et Financière
valerie.filiatre@amoeba-biocide.com

Amoéba’s ambition is to become a major player in the treatment of bacterial risk in the fields of water, healthcare and plant protection. Our biological solution is an alternative to chemical products widely used today. Amoéba is currently focusing on the market of industrial cooling towers estimated at €1.7Bn (1) on a global chemicalbiocide market for water treatment, evaluated at €21Bn (2) and on the biocontrol market for plant protectionestimated globally at €1.6Bn (4). In the future, the Company is looking at developing new applications such aschronic wound care, estimated at € 751 million (3) in the USA. Sales of associated products with healthcare, biocides and crop protection are subject to the Company being granted local regulatory market authorizations. The Company is currently in a trial phase for biocidal and plant protection applications and does not market any products.

Created in 2010, based in Chassieu (Lyon, France) with a subsidiary in Canada and in the United States, Amoéba is quoted on the compartment C of Euronext Paris. The Company is a member of the BPIfrance Excellence network and is eligible for the PEA-PME SME equity savings plan setup.

(1): Amoéba data combined from sources: DRIRE 2013, Eurostat, ARHIA 2013
(2): Sources combined by Amoéba from water treaters, Freedonia, Eurostat et MarketsandMarkets
(3): BCC Research, "Markets for Advanced Wound Management Technologies," Wellesley, MA, 2017
(4): Biopesticides Worldwide Market 2013, CPL, Wallingford, UK

Popular Posts

Regulatories information and financial documents
Amoéba communication 2.0
World water day
Amoéba attracts the German market
Amoéba enters the Canadian market
Success of Amoéba’s initial public offering

© 2019 Amoeba All rights reserved

Legal information